Abstract
PD-217014, a new GABA analog (1 alpha,3 alpha,5 alpha-3-aminomethyl-bicyclo[3.2.0]heptane-3-acetic acid), inhibited [(3)H]-gabapentin binding to alpha(2)delta subunit of voltage-gated calcium channels in a concentration-dependent manner (K(i) = 18 nmol/l). Oral treatment with PD-217014 significantly inhibited the visceral hypersensitivity induced by an intra-colonic injection of trinitrobenzene sulfonic acid in rats. The anti-hyperalgesic effect of PD-217014 increased in a dose-dependent manner, and reached a plateau level at 60 mg/kg p.o. The visceral analgesia produced by PD-217014 at 30 and 60 mg/kg p.o. correlated with blood concentrations within 4 h after dosing, and maximal efficacy was obtained 2 h after dosing when the maximal blood concentration was achieved at either dose. These results indicate that PD-217014 is a potent alpha(2)delta ligand and possesses visceral analgesic activity.
(c) 2008 S. Karger AG, Basel.
MeSH terms
-
Analgesics / chemistry
-
Analgesics / pharmacology
-
Analgesics / therapeutic use
-
Animals
-
Binding Sites / drug effects
-
Bridged Bicyclo Compounds / pharmacology*
-
Bridged Bicyclo Compounds / therapeutic use
-
Calcium Channels / metabolism*
-
Calcium Channels, L-Type
-
Dose-Response Relationship, Drug
-
Hyperalgesia / drug therapy*
-
Hyperalgesia / metabolism
-
Hyperalgesia / pathology
-
Ligands
-
Male
-
Pain Measurement / drug effects
-
Pain Measurement / methods
-
Rats
-
Rats, Sprague-Dawley
-
Swine
-
Trinitrobenzenesulfonic Acid / toxicity*
-
Viscera / drug effects*
-
Viscera / metabolism
-
Viscera / pathology
-
gamma-Aminobutyric Acid / analogs & derivatives*
-
gamma-Aminobutyric Acid / pharmacology
-
gamma-Aminobutyric Acid / therapeutic use
Substances
-
1 alpha,3 alpha,5 alpha-3-aminomethyl-bicyclo(3.2.0)heptane-3-acetic acid
-
Analgesics
-
Bridged Bicyclo Compounds
-
Cacna2d1 protein, rat
-
Calcium Channels
-
Calcium Channels, L-Type
-
Ligands
-
gamma-Aminobutyric Acid
-
Trinitrobenzenesulfonic Acid